PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of this study is to assess the pharmacokinetics and pharmacodynamics of gefurulimab in pediatric participants with AChR+ gMG for the duration of the study.
Epistemonikos ID: 8928695d728999cc39033490aab044a4486cc920
First added on: Oct 01, 2024